- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0028886

About Raabta Pharma Private Limited
Data last updated:
Raabta Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 23 August 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24236TG2018PTC126275. Its GSTIN is 36AAJCR0974L1ZV (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Gudelli Supriya Patak and Pusati Bhaskar Reddy.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Flat No. 505 Vaishnavi Exotica Street No. 3 Kakatiya Nagar Habsiguda, Hyderabad, Telangana, India – 500007.
As per the financials filed for FY 2022, the company reported a revenue of ₹50.31 Lakh, a growth of 75% compared to the previous year. For the same year it recorded a net loss of ₹30.05 Lakh (net margin -59.7%) and EBITDA of -₹23.56 Lakh (EBITDA margin -46.8%).
As per MCA filings, the company has open charges of ₹40.25 Lakh on record.
Raabta Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0028886). For more details, the company can be reached via its website raabtapharma.com.
Company details
Recognitions & Rankings of Raabta Pharma
Contact details
Raabta Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is raabtapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFlat No. 505 Vaishnavi Exotica Street No. 3 Kakatiya Nagar Habsiguda, Hyderabad, Telangana, India – 500007
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Raabta Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Raabta Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Raabta Pharma Private Limited, buy the company report.
Financials of Raabta Pharma Private Limited
FY 2022 filings availableRaabta Pharma Private Limited reported revenue of ₹50.31 Lakh (up 75% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue rose 75% in the latest year. EBITDA fell 320% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹23.56 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹30.05 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -46.8% | |||
| Net Profit Margin | -59.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Raabta Pharma Private Limited, buy the company report.
Board of directors of Raabta Pharma Private Limited
Raabta Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gudelli Supriya Patak Also directs: CNS Labs Private Limited | Director | 23 Aug 2018 | 8 Years 2 Months | Current |
| Pusati Bhaskar Reddy | Director | 23 Aug 2018 | 8 Years 2 Months | Current |
Auditor
Raabta Pharma Private Limited is audited by K Bhaskar & Associates for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K Bhaskar & Associates | FY 2021 | 020817S |
Shareholding
The shareholding of Raabta Pharma Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Raabta Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Aug 2021 | 100485138 | City Union Bank Limited | ₹40.25 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Raabta Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Raabta Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Raabta Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAJCR0974L1ZV | Telangana | Active | 01 Oct 2019 |
| 37AAJCR0974L1ZT | Andhra Pradesh | Active | 08 Feb 2020 |
To see the full GST registrations and return filing status of Raabta Pharma Private Limited, buy the company report.
Recent activity
Raabta Pharma Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Surendra Babu Labbi ceased to be Director on 27 Nov 2019.
Frequently asked questions
Raabta Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 23 August 2018 (8+ years old) and is registered under CIN U24236TG2018PTC126275.
Raabta Pharma has 2 current directors:
- Gudelli Supriya Patak - Director
- Pusati Bhaskar Reddy - Director
The latest financial statements of Raabta Pharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Raabta Pharma is 36AAJCR0974L1ZV, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AAJCR0974L1ZT (Andhra Pradesh).
The CIN (Corporate Identification Number) of Raabta Pharma is U24236TG2018PTC126275. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Raabta Pharma was incorporated on 23 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
Surendra Babu Labbi ceased to be Director on 27 Nov 2019. Gudelli Supriya Patak was appointed as Director on 23 Aug 2018. Pusati Bhaskar Reddy was appointed as Director on 23 Aug 2018.
Yes, Raabta Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0028886).
Raabta Pharma can be reached through the website raabtapharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Raabta Pharma is at Flat No. 505 Vaishnavi Exotica Street No. 3 Kakatiya Nagar Habsiguda, Hyderabad, Telangana, India – 500007.